Prevalence and predictors of injecting-related injury and disease among clients of Australia's needle and syringe programs

Australian and New Zealand Journal of Public Health

Volumn 32, Issue 1, 2008, Pages 34-37

  Topp, Libby ^a   Iversen, Jenny ^a   Conroy, Andrew ^b   Salmon, Allison M ^a   Maher, Lisa ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b QUEENSLAND HEALTH   (Australia)

Author keywords

Epidemiology; Injections; Needle exchange programs; Substance abuse; Vascular skin diseases

Indexed keywords

BUPRENORPHINE; COCAINE; DIAMORPHINE; HEPATITIS C ANTIBODY; METHADONE; METHAMPHETAMINE; MORPHINE; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; BISEXUALITY; BLOOD ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE DURATION; DISEASE SEVERITY; ENDOCARDITIS; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HETEROSEXUALITY; HUMAN; INJECTION SITE ABSCESS; INJECTION SITE CONTUSION; INJECTION SITE INFECTION; INJECTION SITE SCAR; INJECTION SITE THROMBOSIS; INTRAVENOUS DRUG ABUSE; LIFESPAN; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PREDICTION; PREVALENCE; PREVENTIVE HEALTH SERVICE; PROSTITUTION; RISK FACTOR; SELF REPORT; SEPTICEMIA; SEX DIFFERENCE; VEIN INJURY;

ADOLESCENT; ADULT; AGED; AUSTRALIA; BLOOD VESSELS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; INFECTION; INJECTIONS; MALE; MIDDLE AGED; NEEDLE-EXCHANGE PROGRAMS; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SKIN DISEASES; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 40449092074     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2008.00163.x     Document Type: Article

References (24)

1. Woodburn KR, Murie JA. Vascular complications of injecting drug misuse. Br J Surg. 1996;83:1329-34.
2. Morrison A, Elliot L, Gruer L. Injecting-related harm and treatment-seeking behaviour among injecting drug users. Addiction. 1997;92:1349-52.
3. del Giudice P. Cutaneous complications of intravenous drug abuse. Br J Dermatol. 2004;150:1-10.
4. Abrahamian FM. Update: Clostridium novyi and unexplained illness among injecting-drug users - Scotland, Ireland, and England, April-June 2000. Ann Emerg Med. 2001;37:107-9.
5. Bohlen LM, Muhlemann K, Dubuis O, Aebi C, et al. Outbreak among drug users caused by a clonal strain of group A streptococcus. Emerg Infect Dis. 2000;6:175-9.
6. Iversen J, Topp L, Maher L. Australian NSP Survey National Data Report 2002-2006. Sydney (AUST): National Centre in HIV Epidemiology and Clinical Research, University of New South Wales; 2007.
7. MacDonald M, Wodak AD, Ali R, Crofts N, Cunningham PH, Dolan KA, et al. on behalf of the Collaboration of Australian Needle Exchanges. HIV prevalence and risk behaviour in needle exchange attenders: a national study. Med J Aust. 1997;166:237-40.
8. Spijkerman IJ, van Ameijden EJ, Mientjes GH, Coutinho RA, et al. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injecting drug users. J Clin Epidemiol. 1996;49:1149-54.
9. Freidman SR, Ompad DC, Maslow C, Young R, et al. HIV prevalence, risk behaviours, and high-risk sexual and injecting networks among young women injectors who have sex with women. Am J Public Health. 2003;93:902-6.
10. Richters J, Song A, Prestage G, Clayton S, et al. Health of Lesbian, Bisexual and Queer Women in Sydney: The 2004 Sydhey Women and Sexual Health Survey. Sydney (AUST): National Centre in HIV Social Research; 2005.
11. Darke S, Ross J, Kaye S. Physical injecting sites among injecting drug users in Sydney, Australia. Drug Alcohol Depend. 2001;62:77-82.
12. Kral AH, Bluthenthal RN, Erringer EA, Lorvick J, et al. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction. 1999;94:675-83.
13. Darke S, Topp L, Ross J. The injection of methadone and benzodiazepines among Sydney injecting drug users 1996-2000: 5-year monitoring of trends fromthe Illicit Drug Reporting System. Drug Alcohol Rev. 2002;21:27-32.
14. MacRae R, Aalto E. Gendered power dynamics and HIV risk in drug-using sexual relationships. AIDS Care. 2000;12:505-15.
15. Spitall PM, Schechter MT. Injection drug use and despair through the lens of gender. CMAJ. 2001;164:802-3.
16. Marshall J, Gregorio D, Walsh D. Sex differences in illness behavior: Care seeking among cancer patients. J Health Soc Behav. 1982;23:197-204.
17. Darke S, Ross J, Hall W. Prevalence and correlates of the injection of methadone syrup in Sydney, Australia. Drug Alcohol Depend. 1996;45:191-8.
18. Degenhardt LJ, Black E, Breen C, Bruno R, et al. Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia. Drug Alcohol Rev. 2006;25:403-12.
19. Jenkinson RA, Clark NC, Fry CL, Dobbin M. Buprenorphine diversion and injection in Melbourne, Australia: An emerging issue? Addict. 2005;100:197-205.
20. Harris HW, Young DM. Care of injecting drug users with soft tissue infections in San Fransisco, California. Arch Surg. 2002;137:1217-22.
21. HsiehY-H, Khalil A, Wazir S, Majmudar M, et al. Factors predicting differential duration of hospital stay among inner-city injection drug users with skin/soft tissue infections. Acad Emerg Med. 2006;13:S143-S4.
22. Gordon RJ, Lowy FD. Bacterial infections in drug users. N Engl J Med. 2005;353:1945-54.
23. Palepu A, Tyndall MW, Leon H, Muller J, et al. Hospital utilization and costs among a cohort of injecting drug users. CMAJ. 2001;165:415-20.
24. Kerr T, Wood E, Grafstein E, Ishida T, et al. High rates of primary care and emergency department use among injecting drug users in Vancouver. J Public Health. 2004;27:62-6.